Latest News

Common outcome measures required for neurofibromatosis clinical trials

As potentially effective new treatments for neurofibromatosis (NF) are developed, standardized research approaches -- including outcome measures specific to NF -- are needed. The first report from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration has now been published.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Quitting cigarettes tougher for heavy-drinking smokers, but phone counseling can help

  • Suicide risk falls substantially after talk therapy

  • Breakthrough discovery contributes to future treatment of multiple sclerosis, autoimmune inflammation

  • Motor coordination issues in autism are caused by abnormal neural connections

  • Schizophrenia may be triggered by excess protein during brain development

  • The sound of status: People know high-power voices when they hear them

  • Neurodegenerative diseases: Has a possible new lead been found?

  • Declining loneliness among American teenagers

  • Protein that rouses brain from sleep may be target for Alzheimer's prevention

  • Does dip decrease or deepen addiction to nicotine?

  •